Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Apr. 02, 2017	Mar. 27, 2016
Revenues	$ 22,035	$ 20,833
Cost of products sold	15,145	14,428
Gross profit	6,890	6,405
Operating expenses:
Research and development	1,138	1,656
Selling, general and administrative	3,911	4,267
Total operating expenses	5,049	5,923
Operating income	1,841	482
Other expense:
Interest and financing expense	(68)	(102)
Miscellaneous	(25)	(11)
Total other expense	(93)	(113)
Income before income taxes	1,748	369
Income tax provision	(87)	(88)
Net income	1,661	281
Net loss (income) attributable to non-controlling interest	(6)	18
Net income attributable to Ultralife Corporation	1,655	299
Other comprehensive income (loss):
Foreign currency translation adjustments	259	(279)
Comprehensive income attributable to Ultralife Corporation	$ 1,914	$ 20
Net income per share attributable to Ultralife common shareholders – basic (in dollars per share)	$ 0.11	$ 0.02
Net income per share attributable to Ultralife common shareholders – diluted (in dollars per share)	$ 0.11	$ 0.02
Weighted average shares outstanding – basic (in shares)	15,412	15,323
Potential common shares (in shares)	244	343
Weighted average shares outstanding – diluted (in shares)	15,656	15,666